Optigenex Inc. Agrees to Long-Term License Granting Promethean Corporation Exclusive North American Distribution Rights

NEW YORK, NY, Jan 04 (MARKET WIRE) --
Optigenex Inc. (PINKSHEETS: OPGX) announced today the signing of a long
term exclusive license agreement with Promethean Corporation for
distribution and marketing of branded cosmeceutical and dietary
supplement products containing AC-11(R), a patented, all-natural rain
forest botanical extract manufactured by Optigenex that helps the body's
natural ability to repair damaged DNA as a result of overexposure to the
sun and other environmental stressors. Under the new agreement,
Promethean through its wholly owned subsidiary, Ceres Living will market
the "AIO Premium Cellular Health(TM)" line of advanced dietary
supplements, as well as specially formulated next generation topical skin
care products with AC-11(R). The contract vests Promethean with
exclusivity in the North American "Direct Sales" or "Network Marketing"
distribution channel coinciding with the expiration of similar channel
rights previously held by former licensee. In addition to North American
Direct Sales channel rights, Promethean will exercise exclusive rights
and sublicensing rights in all channels in China and certain additional
non-exclusive channel rights in North and Central America and Australia.

Daniel Zwiren, president and CEO of Optigenex Inc. said, "Teaming up with
Promethean promises to be the perfect start of a new decade for Optigenex.
The management at Promethean and its wholly owned subsidiary, Ceres Living
are professionals with a proven record in business management and the
Direct Sales (Network Marketing) distribution channel. We are excited to
see the AC-11(R) brand and our unique theme of DNA health associated with
the innovative technologies behind AIO Premium Cellular Health(TM)."

Matthew Henninger, Chairman & CEO of Promethean Corporation, added, "We
had wanted to work with the Optigenex team and their product AC-11(R)
since before we developed the AIO Premium Cellular Health(TM) product
line. Now that timing has allowed our two companies to align, we look
forward to continued collaborative research and development of products
that offer the best technologies in cellular health and nutrition."

About Optigenex Inc.:

Optigenex Inc. is a technology-based developer of proprietary anti-aging
ingredients for various health-related industries, including wellness,
beauty and dietary supplements. AC-11(R) (formerly known as C-MED-100(R))
is the company's patented all-natural extract from the medicinal herb
Uncaria tomentosa. From its origins in the Amazon Rain Forest, AC-11(R)
delivers a unique bioactive compound of water soluble carboxy alkyl esters
(CAEs(TM)) that form the backbone of the company's revolutionary approach
to DNA care and healthy aging. For more information about Optigenex please
visit our website: www.optigenex.com

About Promethean Corporation:

Promethean Corp. ("Promethean") is a New York City based Health Care
related products and services company that develops, manufactures and
distributes its own products. The company through its wholly owned
subsidiary, Ceres Living produces and sells the AIO Premium Cellular
Health(TM) product line. The company develops Advanced Nutraceuticals,
Advanced Personal Care products and other Nutritional and Wellness
Products and Services that it plans to sell in multiple channels of
distribution. For more information about Promethean Corporation, please
contact the company at (212)-355-5129.

*The statements made in this press release have not been evaluated by the
Food and Drug Administration (FDA). The products mentioned herein are not
intended to treat, diagnose, cure or prevent any disease.

Contact:
Optigenex Inc.
Dan Zwiren
president and CEO Optigenex Inc.
dzwiren@optigenex.com
201 355 2098

Copyright 2010, Market Wire, All rights reserved.

-0-